Dokumen

Perbincangan Teknikal Ramalan Bermusim Opsyen

Dokumen Piramal Pharma Limited

Terokai dokumen terkini dari Piramal Pharma Limited, termasuk pemfailan regulatori dan pendedahan korporat yang menawarkan cerapan kepada prestasi dan strategi syarikat. Gunakan sumber-sumber ini untuk menyokong keputusan pelaburan termaklum.

Rakan kongsi data

Huraian

Reported date

Borang

2026

Q1 25/26

Jul 29, 2025

Transcript

Slides

Interim report

2025

Q4 24/25

Mei 15, 2025

Transcript

Slides

Interim report

Q3 24/25

Jan 29, 2025

Transcript

Interim report

Slides

Q2 24/25

Okt 24, 2024

Interim report

Slides

Q1 24/25

Jul 26, 2024

Interim report

Slides

2024

Investor Presentation

Sep 23, 2024

Slides

Investor Presentation

Jul 10, 2024

Slides

Q4 23/24

Mei 13, 2024

Interim report

Slides

Q3 23/24

Jan 31, 2024

Interim report

Slides

Corporate Presentation

Jan 04, 2024

Slides

Q2 23/24

Okt 30, 2023

Interim report

Slides

Q1 23/24

Ogos 04, 2023

Interim report

Slides

2023

Q4 22/23

Mei 25, 2023

Interim report

Slides

Q3 22/23

Feb 09, 2023

Interim report

Slides

Q2 22/23

Nov 08, 2022

Interim report

Slides

Q1 22/23

Jul 29, 2022

Interim report

Slides

2022

Investor Presentation

Ogos 12, 2022

Slides

Q4 21/22

Mei 26, 2022

Interim report

Slides

Investor Presentation

Apr 07, 2022

Slides

Q3 21/22

Feb 10, 2022

Interim report

Slides

Q2 21/22

Nov 11, 2021

Report

Slides

Q1 21/22

Ogos 06, 2021

Interim report

Slides

2021

Investor Presentation

Nov 15, 2021

Slides